| Primary information |
|---|
| ID | 1099 |
| Peptide Name | gp41 portion of gp160 peptide |
| Sequence | LSVWGIRQLRARLLALE |
| Length | 17 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Nature | Protein Derived |
| Source of Origin | GP160 protein of HIV |
| Target | NA |
| Mechanism of Action | Induced progressive inhibition of PHA-induced lymphocyte proliferation |
| In vitro/In vivo | Both |
| Cell Line | CTLL-2, murine IL-2-dependent cell line |
| Inhibition Concentartion | NA |
| In vivo Model | Balb/c mice, 4-12 months old |
| Assay | Proliferation assay |
| Lethal Dose | NA |
| Combination Therapy | Interferon α, PGE 2 |
| Pubmed ID | 8582788 |
| Year of Publication | 1995 |
| 3-D Structure |  View in Jmol or Download Structure |
